Impulse Oscillometry

Clinical Rationale And Mechanism

Impulse Oscillometry offers an effort-independent, non-invasive method to assess pulmonary mechanics during spontaneous tidal breathing.
The device superimposes small pressure oscillations, typically ranging from 5 to 35 Hz, via a mouthpiece to measure overall respiratory system impedance.
Impedance is mathematically separated into two distinct forces: airway resistance (Rrs) and reactance (Xrs).
The effort-independent nature circumvents the need for maximal forced expiratory maneuvers, achieving a feasibility exceeding 85 to 95 percent in trained centers.
This makes IOS the ideal diagnostic modality for preschoolers (aged 2 to 6 years), uncooperative children, and patients with underlying neuromuscular weaknesses.

Parameter	Physiological Significance
R5	Represents total airway resistance across both central and peripheral airways.
R20	Represents large, central airway resistance.
R5–R20	Quantifies small-airway dysfunction (SAD) and peripheral airway obstruction.
X5	Represents reactance, indicating airway distensibility and the presence of peripheral air trapping.
AX	Represents the reactance area; correlates strongly with poor clinical asthma control and predicts future exacerbations.
Fres	Represents the resonant frequency where airway inertia and capacitance are equal.

Recent 2026 calibrations establish specific cut-offs for pediatric obstruction: AX >1.54 $k P a \cdot L^{- 1}$ and Fres >20.41 Hz in children aged 6 to 11 years.
A post-bronchodilator drop of 20 percent in Fres combined with a 40 percent drop in AX strongly predicts reversible obstruction.
The American Thoracic Society and European Respiratory Society (ATS/ERS) 2025 Technical Standards define a positive Bronchodilator Response (BDR) as a $\geq$ 25 to 30 percent drop in R5, or the complete normalization of z-scores.
Interpretation must utilize the Lower Limit of Normal (LLN at the 5th percentile) derived from the GLI 2025 multi-ethnic reference equations.

Asthma And Wheezing: IOS detects peripheral airway obstruction and small-airway dysfunction frequently missed by the traditional FEV1 metric. Abnormal IOS parameters at age 4 firmly predict active asthma and impaired lung capacity by school age.
Intra-Breath Analysis: Advanced temporal resolution within respiratory cycles links early lower respiratory infections to elevated end-inspiratory resistance.
Other Pulmonary Disorders: IOS accurately diagnoses reversible obstruction in early Bronchopulmonary Dysplasia (BPD) and highlights distinct reactance abnormalities in Primary Ciliary Dyskinesia (PCD) compared to Cystic Fibrosis (CF).

Global Initiative For Asthma (GINA 2025/2026): Recommends IOS in specialist settings for persistent symptoms in children $\leq$ 5 years to accurately assess disease control and guide therapy step-up.
Indian Academy Of Pediatrics (IAP): Endorses IOS for evaluating preschool wheezing. Objective testing is strictly mandated for refractory cases prior to initiating long-term inhaled controllers or advanced biologic therapies.
Public Health Integration: Ministry of Health and Family Welfare (MoHFW) digital pilots aim to integrate portable IOS within primary health centers to support early detection under the National Clean Air Programme (NCAP).